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Abstract
Background: The aim of this prospective study was to assess the diagnostic value of NT-proBNP
and the concordance with Tissue Doppler Echocardiography (including strain and longitudinal
displacement) in diastolic and systolic heart failure.
Methods and results: 137 consecutive clinically stable patients were included (42 healthy
controls, 43 with diastolic heart failure, 52 with systolic heart failure). In diastolic heart failure, basal
septal strain was reduced (-24.8 ± 8.1% vs. controls. -18.5 ± 5.3%, p < 0.0001). In all patients with
preserved systolic function, septal basal longitudinal displacement was impaired in patients with
increased left-ventricular filling pressures (E/E' < 8: 13.5 mm ± 3.3 mm vs. E/E' > 15: 8.5 mm ± 2.3
mm, p = 0.001) parallel to NT-proBNP elevation (E/E' < 8: 45.8 pg/ml, IQR: 172.5 pg/ml vs. E/E' >
15: 402.0 pg/ml, IQR: 1337.2 pg/ml; p = 0.0007). In ROC analysis, NT-proBNP could detect patients
with reduced left ventricular systolic function (LVEF ≥ 55%) with a good diagnostic accuracy.
However, the diagnostic accuracy of NT-proBNP to detect diastolic dysfunction was lower.
Conclusion: Subtle changes of longitudinal myocardial function begin in diastolic heart failure and
are further increased in systolic heart failure. In patients with preserved LV function, a complex
approach with the integration of multiple parameters including Tissue Doppler echocardiography
and NT-proBNP is necessary to classify patients.
Background
The prevalence of both systolic and diastolic heart failure
is high and the prognosis is comparably poor. The preva-
lence of diastolic heart failure is increasing and the sur-
vival rates remain low, whereas the survival rates of
systolic heart failure have improved in recent years.
Diastolic heart failure is characterized by abnormal myo-
cardial relaxation and increased passive stiffness and is
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hard to distinguish from systolic heart failure by clinical
examination alone [1-8].
It was suggested that there is no isolated diastolic dysfunc-
tion, but that there is a continuum from normal to
impaired diastolic and then systolic dysfunction (concept
of "single syndrome"). The impairment of the longitudi-
nal systolic function measured by Tissue Doppler Imaging
(TDI) in patients with diastolic dysfunction supports this
concept [9-11]. In contrast, the "two syndromes" concept
claims two different pathological entities in systolic and
diastolic heart failure. However, there is no final consen-
sus on the taxonomy and the optimal diagnostic algo-
rithm for the detection of diastolic dysfunction.
Symptoms of heart failure, biomarkers, stress tests, and
echocardiography are important elements in the diagnos-
tic work up [12].
The non-invasive methods to diagnose heart failure
include echocardiography and cardiac biomakers.
Increased left-ventricular filling pressure is believed to
induce myocardial wall-stress, the release of natriuretic
peptides and increased E/E'-ratio. Diastolic heart failure is
unlikely if E/E' is < 8, an E/E' 8–15 is suggestive of but not
diagnostic of diastolic heart failure [13,14].
In addition to myocardial velocity measurements, new
sensitive TDI-derived measurements of systolic function
were introduced recently: Strain and longitudinal dis-
placement [15]. Strain measures compression and disten-
sion of myocardial segments ("deformation imaging")
and is reduced in systolic dysfunction [16,17]. Longitudi-
nal displacement measures myocardial motion ampli-
tudes in systole and visualizes the segmental velocity-time
integrals. It correlates with longitudinal systolic function
[18] but has not yet been examined in isolated diastolic
dysfunction.
Natriuretic peptides (BNP and the hormonally inactive
NT-proBNP) are significantly elevated in systolic and in
less so in diastolic heart failure [19-22]. NT-proBNP corre-
lates to prognosis in systolic heart failure [23,24], but its
diagnostic value in stable asymptomatic patients with
diastolic heart failure is still controversial.
The aim of this study was to assess the diagnostic value of
NT-proBNP and the concordance with Tissue Doppler
Echocardiography (Strain imaging, longitudinal displace-
ment, E/E') in diastolic and systolic heart failure. We pos-
tulate that the integration of these parameters improves
the severity estimation of systolic and diastolic heart fail-
ure.
Methods
Patients
In this prospective monocentric study (enrolment
2004–2005), 137 consecutive clinically stable out- and in-
patients with a clinical indication for echocardiography
from medical and surgical departments were included.
Exclusion criteria: atrial fibrillation, relevant valvular
heart disease exceeding mild mitral or aortic valve disease,
prosthetic heart valves, pulmonary hypertension, myocar-
dial infarction < 3 months prior to study inclusion, termi-
nal renal failure, creatinine > 2.5 mg/dl, pregnancy, age <
18 years. The blood for NT-proBNP measurements (Elec-
sys proBNP, Roche Diagnostics, Germany [25] was drawn
after echocardiography, centrifuged and frozen at -80°C
immediately. The echocardiography examiners were
blinded to the NT-proBNP values. The creatinine clear-
ance was calculated as previously described [26,27].
Written informed consent was obtained from each
patient. The ethics committee of the Charité University
Hospital approved the protocol.
Echocardiography
Transthoracic echocardiography was performed according
to the ASE recommendations [28] by Vivid 7 Dimension
(M3S 1.5–4.0 MHz transducer; GE Vingmed, Horton,
Norway). The images were stored digitally and analyzed
off-line by EchoPac PC Dimension (GE Vingmed, Horton
Norway). Echocardiographic examinations included the
trans-mitral inflow profile (E/A), TDI measurement of the
ratio of the early-to-late annular velocity (E'/A') in the
basal septum and left lateral myocardium at the mitral
annulus, the E/E' ratio using the average of the basal septal
and basal lateral E', the systolic basal septal and lateral
myocardial velocities (S') as well as basal septal and lateral
Strain and longitudinal displacement. (For acquisition of
the TDI images: see additional file 1 and additional file
2]. All measurements were performed in the apical four
chamber view; three beats were stored and analyzed.
The LVEF was calculated according to Simpson's rule [29].
A normal LVEF was defined as ≥ 55%, 30–55% is mild-
moderately abnormal, a LVEF < 30% is severely abnormal
according to [30]. LV mass was computed according to the
ASE cube method [31].
Diastolic heart failure was defined as previously
described: normal LVEF (≥ 55%) [30], E/E' > 10 [13,14],
E/A < 1 [32,33]. The transmital flow and TDI parameters
were adjusted to age-related cut-points according to
[33,34].
The patients were classified as normal controls (group 1),
diastolic heart failure with preserved left ventricular func-Cardiovascular Ultrasound 2008, 6:45 http://www.cardiovascularultrasound.com/content/6/1/45
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tion (LVEF ≥ 55%, group 2), systolic heart failure (LVEF <
55%, group 3).
Statistics
Statistics were calculated by SPSS (version 12.0, Chicago,
Ill, USA). Descriptive statistics of parametric variables are
expressed as mean (± SD). Nonparametric variables are
expressed as median (inter-quartile range, IQR, of 25 and
75 percentiles).
The comparison of echocardiographic parameters
between groups was calculated by Wilcoxon test for non-
parametric data. The Dunnett test was used for compari-
son to normal findings [35]. Dichotomized data were
analyzed by the Chi2-test. The level of significance was p =
0.05.
ROC (Receiver Operator Characteristics) analysis was per-
formed to calculate sensitivity, specificity, negative and
positive predictive values and an optimal cut-point of NT-
proBNP to detect systolic or diastolic dysfunction. The
optimal cut-off point was assessed according to Youden
[36].
Results
137 patients were included. 42 patients had normal systo-
lic and diastolic function (group 1), 43 patients had
diastolic dysfunction (group 2), 52 patients had systolic
dysfunction with an EF < 55% (group 3).
The baseline characteristics of the patients are listed in
table 1; the echocardiographic findings are listed in table
2. Patients with reduced LVEF (< 55%) had significantly
increased NT-proBNP values compared to the healthy
controls. Strain and longitudinal displacement parame-
ters were significantly reduced in severely reduced LVEF
compared to controls (table 3, figure 1).
The ROC analysis to discriminate between normal LVEF
(n = 88) and reduced LVEF (n = 49) had an area under the
curve of 0.844, which indicates a good diagnostic accu-
racy. The best cut-off for this discrimination was 489 pg/
ml (sensitivity 81.6%, specificity 85.2%, PPV 75.5% and
NPV 89.3%, OR 25.6, Youden Index 0.67). The ROC anal-
ysis to discriminate between normal echocardiography (n
= 42) and impaired diastolic and/or systolic function (n =
95) had an area under the curve of 0.763, which indicates
a fair diagnostic accuracy. The best cut-off for this discrim-
ination was 97 pg/ml (sensitivity 80.4%, specificity
64.3%, PPV 83.5% and NPV 58.7%, OR 7.2, Youden
Index 0.44) (figure 2)
Dividing the patients with preserved systolic LV function
(groups 1 and 2) by E/E' (cut-point = 8) showed that there
were significant differences in NT-proBNP levels (E/E' < 8:
median NT-proBNP: 45.8, IQR: 172.6 pg/ml, E/E' > 8:
114.6 (261.7), p = 0.01). Classifying these patients by E/
E' < 8, E/E' 8–15 and E/E' > 15 according to [14,33]
revealed that those with increased filling pressures (E/E' >
15) had significantly elevated NT-proBNP and reduced
Table 1: Baseline characteristics of the patients (mean ± SD, for non-parametric values: median, inter-quartile range) p compared to 
normal.
All patients 
(n= 137)
Normal (n= 42) Diastolic dysfunction 
(n = 43)
Systolic dysfunction 
(n = 52)
p (compared to 
normal)
Male sex (%) 88 (65) 23 (55) 23 (54) 43 (83) 1.00/0.0059
Age [y] 53.8 (± 18.1) 37.8 (± 15.9) 62.7 (± 12.5) 59.5 (± 15.2) < 0.0001/< 0.0001
BMI [kg/m2] 25.54 (± 4.36) 23.8 (± 3.4) 26.5 (± 3.8) 26.2 (± 5.1) 0.011/0.018
NT-proBNP [pg/ml] 2378 ± 6253, 
(median 222 
(± 1220)
275.9 ± 519.9 
(median 66.8, ± 185.3)
255.9 ± 137.4(median 
137, ± 256.7)
5832 ± 9185(median 
1583, ± 5109)
0.36/<0.0001
Creatinine clearance 
[ml/min]
87.48 (± 37.89) 107.9 (± 28.6) 82.1 (± 35.0) 78.5 (± 41.3) 0.003/0.0002
Heart rate [/s] 71.6 (± 13.6) 68.3 (± 13.9) 73.1 (± 13.1) 73.5 (± 13.5) 0.68/0.17
Systolic RR [mmHg] 123.0 123.0 136.8 115.4 0.01/0.19
Diastolic RR [mmHg] 74.0 75.4 80.0 71.2 0.21/0.23
coronary artery 
disease (%)
41 (30) 1 (2) 10 (23) 28 (54) 0.0077/0.001
previous myocardial 
infarction (%)
28 (20) 0 5 (12) 21 (40) 0.06/0.0001
arterial hypertension 
(%)
63 (46) 11 (26) 27 (63) 25 (48) 0.0008/0.049
diabetes mellitus (%) 25 (18) 3 (7) 3 (7) 18 (35) 1.00/0.0046
Hyperlipidemia (%) 40 (29) 2 (5) 15 (35) 22 (42) 0.0018/< 0.0001
Smoker (%) 27 (20) 10 (24) 9 (21) 9 (17) 0.8035
ischemic 
cardiomyopathy (%)
30 (22) 0 0 29 (56) < 0.0001Cardiovascular Ultrasound 2008, 6:45 http://www.cardiovascularultrasound.com/content/6/1/45
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longitudinal displacement values compared to patients
with E/E' < 8. Strain, in contrast, was not significantly
impaired. The patients with an E/E' 8–15 did not differ
significantly in NT-proBNP levels compared to patients
with E/E' < 8 or E/E' > 15 (figures 3 and 4).
A division by E/A (cut-point = 1, p = 0.34) or E'/A' (cut-
point = 1, p = 0.54) was not associated with significantly
different NT-proBNP levels. This indicates that increased
E/E' is most closely linked to elevated NT-proBNP.
There was a correlation of peak systolic velocities (S') and
longitudinal displacement with NT-proBNP throughout
the spectrum of our patients (Spearman correlation coef-
ficient was -0.578 (p < 0.0001) for longitudinal displace-
ment and -0.605 (p < 0.001) for S').
Discussion
The main finding of this study is that patients with diasto-
lic and systolic myocardial dysfunction have significantly
reduced basal left ventricular septal and lateral strain com-
pared to healthy controls. Patients with normal LVEF and
elevated left ventricular filling pressures (E/E' > 15) have
significantly reduced longitudinal displacement and sig-
nificantly elevated NT-proBNP. NT-proBNP can detect
patients with a reduced left ventricular systolic function
(LVEF < 55%) with a good diagnostic accuracy in accord-
ance with previous studies [19-24].
In the patients with normal LV function and an elevated
E/E' (8 – 15), the measurement of NT-proBNP does not
add a significant diagnostic information. Therefore, the
diagnostic accuracy of NT-proBNP to detect diastolic dys-
function in these patients is low. Our findings do not fully
support the algorithm recently published consensus state-
ment for the diagnosis of diastolic heart failure that
emphasized E/E' and NT-proBNP [12].
In the grey zone of mildly elevated NT-proBNP and/or an
E/E' between 8 and 15, it remains difficult to diagnose
Table 2: Echocardiographic findings. Mean ± SD
Normal Diastolic dysfunction Systolic dysfunction P (compared to normal)
LVEF (%) 59.5 (± 2.2) 59.1 (± 1.9) 31.5 (± 9.9) 0.99/< 0.0001
Fractional shortening (%) 0.38 (± 0.1) 0.39 (± 0.1) 0.16 (± 0.1) 0.58/< 0.0001
LVEDD (mm) 46.1 (± 4.2) 46.8 (± 5.5) 64.5 (± 12.2) 0.91/< 0.0001
LVESD (mm) 28.6 (± 5.9) 46.4 (± 5.7) 52.1 (± 15.0) 0.99/< 0.0001
PAP (mmHg) 26.1 (± 11.4) 27.0 (± 5.8) 38.4 (± 13.2) 0.94/0.0015
Septum (mm) 10.3 (± 1.9) 12.0 (± 2.8) 11.5 (± 2.0) 0.02/0.0007
Posterior wall (mm) 10.2 (± 1.7) 11.7 (± 1.8) 11.7 (± 1.5) 0.001/< 0.0001
E/A transmitral 1.5 (± 0.5) 0.9 (± 0.2) 1.3 (± 0.8) < 0.0001/0.36
Left ventricular mass [mg] 195.4 (± 59.5) 236.1 (± 58.3) 436.7 (175.9) 0.19/< 0.0001
LVMI 104.1 (± 26.6) 126.0 (± 28.7) 222.6 (± 84.8) 0.14/< 0.0001
Strain septal (%) -24.8 (± 8.1) -18.5 (± 5.3) -16.1 (± 7.0) < 0.0001/< 0.0001
Strain left lateral (%) -21.9 (± 11.4) -17.6 (± 6.0) -14.1 (± 8.3) 0.04/< 0.0001
septal longitudinal displacement (mm) 12.9 (± 3.0) 11.8 (± 2.1) 6.7 (± 3.9) 0.19/< 0.0001
lateral longitudinal displacement (mm) 12.1 (± 3.4) 10.9 (± 2.9) 7.4 (± 4.0) 0.20/<0.0001
TVI velocity E septal (m/s) 0.09 (± 0.02) 0.05 (± 0.01) 0.04 (± 0.02) < 0.0001/< 0.0001
TVI velocity A septal (m/s) 0.06 (± 0.02) 0.08 (± 0.02) 0.06 (± 0.08) 0.26/0.98
TVI velocity S septal (m/s) 0.06 (± 0.01) 0.06 (± 0.01) 0.04 (± 0.01) 0.14/< 0.0001
E/E' 9.14 (± 4.62) 11.44 (± 3.14) 20.56 (± 15.08) 0.44/<0.0001
E'/A' 1.94 (± 1.17) 0.88 (± 0.60) 1.35 (± 0.92) < 0.0001/0.01
Table 3: NT-proBNP and Tissue Doppler echocardiography variables according to reduction in systolic function, n = 137. (median ± 
SD, IQR: inter quartile range for NT-proBNP)
LVEF > 55% LVEF 30–54% LVEF < 30% p vs normal
NT-proBNP 97.0 (180.5) 587.6 (2914.9) 3373.0 (6057) < 0.001/< 0.001
septal longitudinal displacement [mm] 11.5 (± 3.2) 9.3 (± 4.3) 4.9 (± 2.0) 0.015/< 0.001
lateral longitudinal displacement [mm] 12.6 (± 2.6) 8.7 (± 3.6) 4.1 (± 3.3) < 0.001/< 0.001
Strain septal [%] -21.1 (± 7.5) -14.8 (± 6.9) -15.4 (± 7.4) 0.001/0.002
Strain lateral [%] -19.1 (± 9.3) -16.1 (± 9.0) -10.0 (± 5.2) 0.130/< 0.001
TVI S' [m/s] septal 0.09 (± 0.07) 0.06 (± 0.03) 0.04 (± 0.02) 0.002/< 0.001
TVI S' [m/s] lateral 0.06 (± 0.03) 0.05 (± 0.02) 0.03 (± 0.02) < 0.001/< 0.001
E/E' 9.5 (± 4.1) 12.3 (± 12.0) 19.3 (± 16.6) 0.063/< 0.001Cardiovascular Ultrasound 2008, 6:45 http://www.cardiovascularultrasound.com/content/6/1/45
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diastolic heart failure. This could be due to the weak cor-
relation of invasively measured LA filling pressures and E/
E' in this grey zone. The majority of patients with normal
LVEF and invasively measured elevated LA filling pres-
sures had an E/E' between 8 and 15 [37].
This underlines the importance of integrating multiple
echocardiographic parameters and an individual interpre-
tation by experienced cardiologists. Especially in the case
of elevated NT-proBNP of non-cardiac causes (e.g. renal
Longitudinal displacement in patients with normal left ven- tricular function according to E/E' Figure 4
Longitudinal displacement in patients with normal 
left ventricular function according to E/E'. White: lat-
eral, grey: septal longitudinal displacement.
Receiver Operating Characteristic curve to evaluate the diag- nostic accuracy of NT-proBNP to separate patients with  diastolic and/or systolic dysfunction (n = 95) from healthy  controls (n = 42) Figure 2
Receiver Operating Characteristic curve to evaluate 
the diagnostic accuracy of NT-proBNP to separate 
patients with diastolic and/or systolic dysfunction (n = 
95) from healthy controls (n = 42). The area under the 
curve (AUC) = 0.763 (p < 0.0001), Youden index = 0.44. The 
optimal cut-off is 97 pg/ml.
Basal segment strain [%] in patients with severely and moder- ately reduced left ventricular function and patients with pre- served systolic function and diastolic dysfunction Figure 1
Basal segment strain [%] in patients with severely 
and moderately reduced left ventricular function and 
patients with preserved systolic function and diastolic 
dysfunction. Right boxplots: healthy controls. White: lat-
eral, grey: septal strain.
NT-proBNP [pg/ml] in patients with normal systolic function  (n = 85) according to E/E' ratio Figure 3
NT-proBNP [pg/ml] in patients with normal systolic 
function (n = 85) according to E/E' ratio.Cardiovascular Ultrasound 2008, 6:45 http://www.cardiovascularultrasound.com/content/6/1/45
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failure), the diagnostic work-up has to rely on echocardi-
ography alone. In these borderline cases, invasive meas-
urements by a conductance catheter should be considered
to exclude relevant diastolic dysfunction [38].
Why is NT-proBNP not significantly elevated in diastolic
dysfunction compared to healthy controls, but correlates
to filling pressures (E/E')? We speculate that diastolic dys-
function is a process that includes a variety of mechanisms
(LV hypertrophy, abnormal active relaxation, increased
stiffness, increased filling pressures). The trigger for NT-
proBNP release from cardiomyocytes is primarily wall
stress, which is functionally reflected by filling pressures
(E/E').
Our findings support the "single syndrome" theory of
heart failure. Subtle changes of longitudinal myocardial
function (reflected by Strain and longitudinal displace-
ment) begin in diastolic heart failure and are further
increased in systolic heart failure. However, the study by
Yip [9] has seen a progressive decline of left ventricular
long axis function (systolic peak mitral annular velocity)
in patients with diastolic heart failure compared to
healthy controls. We found that peak systolic velocities
are not significantly reduced in diastolic dysfunction. The
cut-off of a normal ejection fraction in their study was
45%. According to [30], a normal LVEF is ≥ 55%. For this
reason, the results of [9] are possibly explained by inclu-
sion bias of patients with reduced LVEF. In their study nei-
ther E/E', Strain or Tracking were measured. In
concordance with our results, Dong [39] did not note a
reduction of TDI systolic velocity (S') in patients with
diastolic dysfunction.
The cut-off values of LVEF, NT-proBNP and E/E' need to
be discussed, because the different studies have used dif-
ferent cut-offs. The definition of a normal LVEF > 50% in
the ESC Guidelines [12] is somewhat arbitrary. Lang [30]
has suggested 55% as the cut-off for a normal LVEF (used
in our study). The lower threshold of 50% will automati-
cally include patients with impairment of longitudinal
function and will therefore alter the sensitivity and specif-
icity for the detection diastolic dysfunction.
The NT-proBNP values physiologically increase with age
[40]; therefore the threshold of 220 pg/ml in the Guide-
lines by Paulus [12] will lead to impaired diagnostic accu-
racy and false-positives in the elderly patients.
Conclusion
In conclusion, we found that in patients with systolic and
diastolic heart failure, E/E', NT-proBNP as well as Strain
and longitudinal displacement add important incremen-
tal information for the severity estimation of heart failure.
In patients with isolated diastolic dysfunction, Strain is
significantly reduced and with increased fillings pressures
longitudinal displacement is impaired, paralleled by an
increase of NT-proBNP. But in a substantial subset of
patients with borderline NT-proBNP and E/E', an individ-
ual analysis of all available data has to be performed.
Limitations
We have excluded patients with atrial fibrillation because
of the difficulty to assess certain diastolic function param-
eters (trans-mitral E/A and myocardial E'/A'). We have
only measured NT-proBNP and not BNP, because recent
head-to-head studies found that BNP and NT-proBNP can
be used comparably [41]. We have not classified diastolic
dysfunction according to restrictive, pseudo-normal or
impaired relaxation. But previous studies have shown that
NT-proBNP is strongly elevated in patients with pseudo-
normal and restrictive filling patterns [19]. In the group of
patients with normal LVEF, there were no patients with
pseudo-normalization or restrictive diastolic dysfunction.
No follow-up of the patients or invasive measurements
were performed.
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